These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11382711)

  • 1. Re-evaluating our approach to calcium and phosphorus management in dialysis patients.
    Keith DS
    Am J Kidney Dis; 2001 Jun; 37(6):1331-3. PubMed ID: 11382711
    [No Abstract]   [Full Text] [Related]  

  • 2. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.
    Block GA; Port FK
    Am J Kidney Dis; 2000 Jun; 35(6):1226-37. PubMed ID: 10845841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in hyperphosphatemia management.
    Slatopolsky E
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S297-9. PubMed ID: 12939384
    [No Abstract]   [Full Text] [Related]  

  • 4. Metastatic cardiac calcification in a patient with chronic renal failure who was undergoing hemodialysis: radiographic and CT findings.
    Jing J; Kawashima A; Sickler K; Raval BK; Oldham SA
    AJR Am J Roentgenol; 1998 Apr; 170(4):903-5. PubMed ID: 9530031
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 6. [Posttransplant regression of uremic tumoral calcinosis].
    de Alarcón RM; Palomares M; Marfil A; Asensio C
    Nefrologia; 2007; 27(3):378-81. PubMed ID: 17725459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium and phosphorus control.
    Lindsay RM; Pierratos A; Lockridge RS
    Contrib Nephrol; 2004; 145():63-68. PubMed ID: 15496792
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperphosphoremia states in hemodialysed patients with chronic renal insufficiency].
    Duchatelle P; Lelievre G; Tacquet A
    Lille Med; 1973 Feb; 18(2):116-24. PubMed ID: 4732957
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma calcium and magnesium fractions in chronic-renal-failure patients on maintenance haemodialysis.
    Varghese Z; Moorhead JF; Wills MR
    Lancet; 1973 Nov; 302(7836):985-8. PubMed ID: 4127276
    [No Abstract]   [Full Text] [Related]  

  • 10. Giant calcified mass in a hemodialysis patient.
    Combalia A; Munoz-Mahamud E; Cofan F
    Kidney Int; 2019 Mar; 95(3):719. PubMed ID: 30784665
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium on trial: beyond a reasonable doubt?
    Nolan CR; Quinibi WY
    Kidney Int; 2003 Jan; 63(1):383; author reply 383-4. PubMed ID: 12472812
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumoral calcinosis, calciphylaxis, hyperparathyroidism and tuberculosis in a dialysis patient.
    Kammoun K; Jarraya F; Hmida MB; Khebir A; Kharrat M; Boudawara T; Mnif J; Hachicha J
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):306-10. PubMed ID: 21422631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Front line of management of hyperphosphatemia in hemodialysis patients].
    Yumita S
    Clin Calcium; 2004 May; 14(5):771-7. PubMed ID: 15577041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
    Savica V; Calò LA; Monardo P; Santoro D; Bellinghieri G
    Nephrol Dial Transplant; 2006 Aug; 21(8):2065-8. PubMed ID: 16766546
    [No Abstract]   [Full Text] [Related]  

  • 15. Conjunctival and corneal changes in chronic renal failure patients treated with maintenance hemodialysis.
    Pahor D; Hojs R; Gracner B
    Ophthalmologica; 1995; 209(1):14-6. PubMed ID: 7715921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of the "adequate blood phosphorus" concept as a risk factor for hyperphosphatemia].
    Douthat WG; Alles A; Marinovich S; Tirado S; Peñalba A; Prudkin S
    Nefrologia; 2003; 23 Suppl 2():95-9. PubMed ID: 12778863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium phosphorus metabolism in dialysis patients with and without mitral anular calcium. Analysis of 30 patients.
    Nestico PF; DePace NL; Kotler MN; Rose LI; Brezin JH; Swartz C; Mintz GS; Schwartz AB
    Am J Cardiol; 1983 Feb; 51(3):497-500. PubMed ID: 6823866
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
    Hoshino J; Ubara Y; Takaichi K
    Clin Calcium; 2004 May; 14(5):731-7. PubMed ID: 15577034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin induced mobilization of calcium and inorganic phosphate in connection with extraosseous calcification in chronic hemodialysis].
    Korz R
    Klin Wochenschr; 1971 Jun; 49(12):684-92. PubMed ID: 4996692
    [No Abstract]   [Full Text] [Related]  

  • 20. Crystal-induced inflammation associated with chronic renal failure treated with periodic hemodialysis.
    Moskowitz RW; Vertes V; Schwartz A; Marshall G; Friedman B
    Am J Med; 1969 Sep; 47(3):450-60. PubMed ID: 5808658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.